vitamin K-antagonist embryofetopathy

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Connect & Download

Disease Overview

A teratogenic disorder observed in a newborn or child of a mother who was exposed to warfarin during pregnancy. Manifestations include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly.


Synonyms

  • DiSala syndrome
  • congenital warfarin syndrome
  • coumarin embryopathy
  • coumarin syndrome
  • di Sala syndrome
  • embryofetopathy due to oral anticoagulant therapy
  • fetal Coumadin syndrome
  • fetal anticoagulant syndrome
  • fetal warfarin syndrome
  • foetal Coumadin syndrome
  • foetal anticoagulant syndrome
  • foetal warfarin syndrome
  • vitamin K antagonist embryofetopathy
  • vitamin K antagonist embryopathy
  • vitamin K antagonists embryofetopathy
  • vitamin K-antagonist embryofetopathy
  • vitamin K-antagonist embryopathy
  • warfarin embryofetopathy
  • warfarin embryopathy
  • warfarin syndrome

Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report

Access State Report Card Data

Please complete this form to access the requested resource.

Please consider sharing some basic information with us.

Name(Required)
This field is hidden when viewing the form